Dot1L-IN-6
Product Specifications
UNSPSC Description
Dot1L-IN-6 is a potent disruptor of telomeric silencing 1-like protein (DOT1L) inhibitor with an IC50 SPA DOT1L of 0.19 nM[1].
Target Antigen
Histone Methyltransferase
Type
Reference compound
Related Pathways
Epigenetics
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/dot1l-in-6.html
Solubility
10 mM in DMSO
Smiles
O=S(C1=CC=C(N[C@H](C2=NC=CC=C2Cl)C3=C4OC(F)(F)OC4=CC=C3)C(NC5=NC(OC)=NC(OC)=N5)=C1)(C)=O
Molecular Weight
606.99
References & Citations
[1]Frédéric Stauffer, et al. New Potent DOT1L Inhibitors for in Vivo Evaluation in Mouse. ACS Med. Chem. Lett. 2019, 10, 12, 1655-1660.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-135129/Dot1L-IN-6-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-135129/
Clinical Information
No Development Reported
CAS Number
2565705-01-1
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
Recombinant Clostridium perfringens Ribonuclease P protein component (rnpA)
Recombinant Clostridium perfringens Ribonuclease P protein component (rnpA)
Recombinant Clostridium perfringens Ribonuclease P protein component (rnpA)
Recombinant Clostridium perfringens Ribonuclease P protein component (rnpA)
Recombinant Clostridium perfringens Ribonuclease P protein component (rnpA)